Oxidants and Iron in Progressive Kidney Disease

Journal of Renal Nutrition

Volumn 16, Issue 3, 2006, Pages 185-189

  Shah, Sudhir V ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745671296     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.04.009     Document Type: Article

References (50)

1. Shah S.V. Oxidants and iron in chronic kidney disease. Kidney Int 66 (2004) S1-S6
2. Halliwell B., and Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease. An overview. Methods Enzymol 186 (1990) 1-85
3. Malle E., Buch T., and Grone H.-J. Myeloperoxidase in kidney disease. Kidney Int 64 (2003) 1956-1967
4. Shin C.S., Moon B.S., Park K.S., et al. Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24 (2001) 733-737
5. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
6. Nishikawa T., Edelstein D., and Brownlee M. The missing link. A single unifying mechanism for diabetic complications. Kidney Int 58 (2000) S26-S30
7. Horie K., Miyata T., Maeda K., et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 100 (1997) 2995-3004
8. Ha H., and Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 48 (1995) S18-S21
9. Kitching A.R., Ruger B.M., and Davis P.F. Oxidant stress in the kidney in experimental diabetes mellitus. Kidney Int 51 (1997) 1314
10. Chen H.-C., Guh J.-Y., Shin S.-J., et al. Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med 135 (2000) 309-315
11. Reddi A.S., and Bollineni J.S. Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats. Kidney Int 59 (2001) 1342-1353
12. Ha H., and Lee H.B. Oxidative stress in diabetic nephropathy. Basic and clinical information. Curr Diab Rep 1 (2001) 282-287
13. Ha H., and Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58 (2000) S19-S25
14. Yan S.D., Schmidt A.M., Anderson G.M., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 (1994) 9889-9897
15. Bierhaus A., Chevion S., Chevion M., et al. Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells. Diabetes 46 (1997) 1481-1490
16. Scivittaro V., Ganz M.B., and Weiss M.F. AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol 289 (2000) F787-F793
17. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1005-L1028
18. Rhee S.G. Redox signaling. Hydrogen peroxide as intracellular messenger. Exp Mol Med 31 (1999) 53-59
19. Meier M., and King G.L. Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med 5 (2000) 173-185
20. Haneda M., Araki S.-I., Togawa M., et al. Activation of MAPK cascade in diabetic glomeruli and mesangial cells cultured under high glucose. Kidney Int 52 (1997) S60-S69
21. Tomlinson D.R. Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42 (1999) 1271-1281
22. Kang S.W., Adler S.G., La Page J., et al. p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli. Kidney Int 60 (2001) S543-S552
23. Iglesias-de la Cruz M.C., Ruiz-Torres P., Alcami J., et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int 59 (2001) 87-95
24. Miyata T., Sugiyama S., Suzuki D., et al. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy. Kidney Int 56 (1999) S54-S56
25. Koya D., Lee I.-K., Ishii H., et al. Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J Am Soc Nephrol 8 (1997) 426-435
26. Craven P.A., Derubertis F.R., Kagan V.E., et al. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes. J Am Soc Nephrol 8 (1997) 1405-1414
27. Ha H., Yu M.-R., and Kim K.H. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Rad Biol Med 26 (1999) 944-950
28. Melhem M.F., Craven P.A., and Derubertis F.R. Effects of dietary supplementation of αlipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12 (2001) 124-133
29. Lal M.A., Korner A., Matsuo Y., et al. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49 (2000) 1381-1389
30. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50 (2001) 2114-2125
31. Ha H., Yu M.-R., Choi Y.J., et al. Activation of protein kinase C-δ and C-ε{lunate} by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 38 (2001) S204-S207
32. Koya D., Hayashi K., Kitada M., et al. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14 (2003) S250-S253
33. Noronha I.L., Fujihara C.K., and Zatz R. The inflammatory component in progressive renal disease-Are interventions possible?. Nephrol Dial Transplant 17 (2002) 363-368
34. Harris D.C., Tay C., and Nankivell B.J. Lysosomal iron accumulation and tubular damage in rat puromycin nephrosis and ageing. Clin Exp Pharmacol Physiol 21 (1994) 73-81
35. Nankivell B.J., Boadle R.A., and Harris D.C.H. Iron accumulation in human chronic renal disease. Am J Kidney Dis 20 (1992) 580-584
36. Nath K.A., Fischereder M., and Hostetter T.H. The role of oxidants in progressive renal injury. Kidney Int 45 (1994) S111-S115
37. Nath K.A., Croatt A.J., and Hostetter T.H. Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol 258 (1990) F1354-F1362
38. Alfrey A.C., Froment D.H., and Hammond W.S. Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int 36 (1989) 753-759
39. Alfrey A.C. Toxicity of tubule fluid iron in the nephrotic syndrome. Am J Physiol 263 (1992) F637-F641
40. Remuzzi A., Puntorieri S., Brugnetti B., et al. Renoprotective effect of low iron diet and its consequence on glomerular hemodynamics. Kidney Int 39 (1991) 647-652
41. Nankivell B.J., Chen J., Boadle R.A., et al. The role of tubular iron accumulation in the remnant kidney. J Am Soc Nephrol 4 (1994) 1598-1607
42. Vaziri N.D. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13 (2004) 93-99
43. Himmelfarb J., Stenvinkel P., Ikizler T.A., et al. The elephant in uremia. Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62 (2002) 1524-1538
44. Ikizler T.A., Morrow J.D., Roberts L.J., et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 58 (2002) 190-197
45. Oberg B.P., McMenamin E., Lucas F.L., et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65 (2004) 1009-1016
46. Lin J.-L., Lin-Tan D.-T., Hsu K.-H., et al. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 348 (2003) 277-286
47. Owda A.K., Alam M.G., and Shah S.V. Environmental lead exposure and chronic renal disease. N Engl J Med 348 (2003) 1810
48. Pennathur S., Wagner J.D., Leeuwenburgh C., et al. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest 107 (2001) 853-860
49. Sharpe P.C., Liu W.-H., Yue K.K.M., et al. Glucose-induced oxidative stress in vascular contractile cells. Diabetes 47 (1998) 801-809
50. Haugen E., and Nath K.A. The involvement of oxidative stress in the progression of renal injury. Blood Purif 17 (1999) 58-65